Physician profile
Paul Lee
NPI 1144996745
$3,800.22
in general payments reported to CMS, 2019-2025
22 companies · $805 in 2025
The $805 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.11 · 2022: $874 · 2023: $854 · 2024: $1,224 · 2025: $805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,345 · Travel and Lodging: $337 · Education: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,344.88 |
| Travel and Lodging | $336.61 |
| Education | $201.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $921.96 | 2021-2024 | Urolift, Solesta |
| Sumitomo Pharma America, INC. | $466.78 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $406.72 | 2022-2025 | |
| Axonics, INC. | $302.75 | 2022-2023 | Axonics |
| Astellas Pharma US INC | $299.78 | 2022-2025 | Xtandi |
| Pfizer INC. | $284.32 | 2022-2025 | |
| Accord Healthcare, INC. | $183.70 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $173.34 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Janssen Biotech, INC. | $128.70 | 2022-2025 | Erleada |
| Halozyme INC | $127.81 | 2023 | |
| Blue Earth Diagnostics | $80.38 | 2021-2023 | |
| Urogen Pharma, INC. | $76.52 | 2023-2025 | Jelmyto |
| Urovant Sciences INC | $61.98 | 2022 | |
| Immunitybio, INC. | $51.72 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.36 | 2022-2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $36.92 | 2023-2024 | Xiaflex |
| Dendreon Pharmaceuticals LLC | $35.38 | 2024-2025 | Provenge |
| Progenics Pharmaceuticals, INC. | $32.70 | 2022-2024 | |
| Boston Scientific Corporation | $24.79 | 2025 | Lithovue |
| Endo USA, INC. | $23.07 | 2025 | Aveed, Xiaflex |
| Tolmar, INC. | $17.58 | 2024 | |
| Angiodynamics, INC. | $14.96 | 2025 | Nanoknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.